The Pharmaceutical Society of Australia’s (PSA) National Board met yesterday and unanimously elected Western Australian pharmacist Dr Fei Sim as PSA’s next national president.
Dr Sim will become the first female to lead PSA since its Federation in 1977.
Associate Professor Chris Freeman, outgoing PSA national president, congratulated Sim on her election.
“PSA has worked incredibly hard to achieve greater diversity within the organisation over the last five years and to reflect the diversity of members we serve.
“I am proud to be handing the torch to PSA’s very first female national president.”
Freeman notes that Fei brings a wealth of experience to the role, having served PSA WA President and, more recently, as the chair of the PSA’s Contemporary Community Pharmacy Practice Community of Speciality Interest.
“Fei has been a great asset to the Society, and we are very excited that she has been elected to lead the profession – continuing to support the important work of pharmacists around Australia.
“I wish her every success in the role and encourage all members to support her in her leadership at this critical time for the profession.”
Michelle Lynch and Dr Shane Jackson will support Fei as National Vice Presidents, creating an experienced and enthusiastic leadership team to take PSA into its next phase of leading the profession.
Renae Beardmore and Anne Todd will be departing the National Board after impactful tenures.
“I thank both Renae, who has served as PSA national vice president, and Anne for their incredible service to the society and the profession, and I am thankful we are able to retain their skills and experience on their respective Branch Committees,” Freeman says.
“Over the three and a half years as National President I am incredibly proud of what PSA has achieved but most of all I am so thankful to all of Australia’s pharmacists and the critical role we play in all sectors of practice.”
Mark Kinsela, PSA CEO, also highlighted Freeman’s achievements since his appointment in 2018.
“Chris has been a fierce advocate for pharmacists around Australia.
“It was his advocacy that led to the Federal Government recognising medicine safety and quality use of medicines as a national health priority area.
“Chris secured a $25 million Federal Government investment to improve medicine safety and quality use of medicine research through the Medical Research Future Fund (MRFF), as well as a $345.7 million commitment to embed pharmacists in residential aged care facilities, improving medicine safety for older Australians.
“He was also instrumental in PSA’s inclusion as a signatory in the Seventh Community Pharmacy Agreement (7CPA) for the first time, ensuring positive outcomes for pharmacists, enabling them to practise to full scope and deliver better health outcomes for their patients.
“I thank Chris for his dedication to PSA’s mission to embed, equip, and enable pharmacists to be at the forefront of healthcare in Australia.”
The new appointments will commence on July 1, 2022.
More about Dr Fei Sim
Dr Fei Sim is a senior lecturer and the coordinator of international engagement at Curtin University’s medical school, Western Australia.
In 2020 she was also made a Fellow of the PSA before being appointed as a director on the PSA National Board in 2021.
Sim has over 14 years of clinical practice experience, and is currently a practising community pharmacist and a community pharmacy proprietor.
Sim also served as PSA’s WA President from 2017 to 2021.
Sim holds a Doctor of Philosophy degree in Pharmacy and a Bachelor of Pharmacy degree with First Class Honours.
She is also qualified pharmacist immuniser and an accredited mental health first aid instructor.
Sim has been recognised for her commitment to patient care, leadership in the pharmacy community and quality of teaching via a number of awards, including:
- The Excellence and Innovation in Teaching Award in 2014
- The PSA WA Early Career Pharmacist Award in 2018
- The National Early Career Pharmacist of The Year Award in 2019.
Sim is an active pharmacy practice researcher, and is also the recipient of a number of research grants and projects focusing on advancing the practice of pharmacy and the implementation of professional pharmacy services in community pharmacy, including the noteworthy JM O’Hara Research Fund grant from the Pharmaceutical Society of West Australia (PSWA) in 2018.
Through this grant, Sim and her team conducted and published on a feasibility study on point-of-care C-reactive protein testing in community pharmacy- a method used to identify whether antibiotic treatment is appropriate or not.
It is hoped this project will contribute towards facilitating antimicrobial stewardship and advancing evidence-based community pharmacy practices.
PSA is the peak national body for pharmacists, representing all of the pharmacy profession in Australia.